二对甲苯磺酸拉帕替尼(GW-572016)

CAS: 388082-77-7 货号: L408619 分子式: C29H26ClFN4O4S·2C7H8O3S 分子量: 925.46 EC号: 879-201-8
有货
级别和纯度: 10mM in DMSO
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
L408619-1ml
现货 Stock Image
¥165.90
请输入您要添加的产品数量

概述

Lapatinib (GW-572016) Ditosylate是一种有效的EGFR和ErbB2抑制剂,IC50分别为10.8和9.2 nM。

Information

Lapatinib (GW-572016) Ditosylate is a potentEGFRandErbB2inhibitor withIC50of 10.8 and 9.2 nM in cell-free assays, respectively.
In vitro

Lapatinib Ditosylate weakly inhibits the activity of ErbB4 with IC50 of 367 nM, and displays >300-fold selectivity for EGFR and ErbB2 over other kinases such as c-Src, c-Raf, MEK, ERK, c-Fms, CDK1, CDK2, p38, Tie-2, and VEGFR2. Lapatinib Ditosylate significantly inhibits receptor autophosphorylation of EGFR and ErbB2 in a dose-dependent manner with IC50 of 170 nM and 80 nM, respectively in HN5 cells; as well as 210 nM and 60 nM, respectively in BT474 cells. Unlike OSI-774 and Iressa (ZD1839) which preferentially inhibit the growth of the EGFR-overexpressing cells, Lapatinib Ditosylate inhibits the growth of both EGFR- and ErbB2-overexpressing cells. Lapatinib Ditosylate displays higher inhibitory activity against EGFR- or ErbB2-overexpressing cells with IC50 of 0.09-0.21 μM, compared with cells expressing low levels of EGFR or ErbB2 with IC50 of 3-12 μM, and exhibits ~100-fold selectivity over the normal fibroblast cells. Lapatinib Ditosylate potently inhibits the outgrowth of EGFR-overexpressing HN5 and A-431 cells, as well as ErbB2-overexpressing BT474 and N87 cells, and significantly induces G1 arrest of HN5 cells and apoptosis of BT474 cells, which are associated with inhibition of AKT phosphorylation.

In vivo

Oral administration of Lapatinib Ditosylate (~100 mg/kg) twice daily significantly inhibits the growth of BT474 and HN5 xenografts in a dose-dependent manner.
Cell Data

cell lines:

Concentrations:Dissolved in DMSO, final concentrations ~100 μM

Incubation Time:72 hours

Powder Purity:≥99%

规格

英文别名
N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,di4-methylbenzenesulfonate
规格或纯度
10mM in DMSO
英文名称
Lapatinib (GW-572016) Ditosylate
生化机理
拉帕替尼(GW-572016)二对甲苯磺酸盐是一种强效的表皮生长因子受体(EGFR)和表皮生长因子受体(ErbB2)抑制剂,在无细胞实验中的 IC50 分别为 10.8 和 9.2 nM。
储存条件
-80℃储存
运输条件
特低温运输
名称和识别符
EC号
879-201-8
分子类型
小分子
Isomeric SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl
MeSH Entry Terms
GW 282974X;GW 572016;GW-282974X;GW-572016;GW282974X;GW572016;lapatinib;lapatinib ditosylate;N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine;Tykerb
分子量
925.46
Reaxy-Rn
11608649
Reaxys-RN link address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=11608649&ln=

高级数据

化学和物理性质
溶解性
Solubility (25°C) In vitro 5%TFA 3.04 mg/mL (11.95 mM); DMSO: 0.1 mg/mL (0.39 mM); Water: Insoluble;
安全和危险性(GHS)
象形图
信号词
警告
危险声明

H360: 可能对生育能力或胎儿造成伤害

H362: 可能对母乳喂养的孩子造成伤害

H372: 长期或反复接触会对器官造成损害

H373: 长期或反复接触可能对器官造成伤害

H413: 可能对水生生物造成长期持续有害影响

预防措施声明

P201: 使用前获取特殊说明

P202: 在阅读并理解所有安全预防措施之前,不要进行操作。

P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。

P263: 避免在怀孕期间/哺乳期间接触。

P264: 处理后要彻底洗手。

P270: 使用本产品时,请勿进食、饮水或吸烟。

P273: 避免释放到环境中。

P281: 根据需要使用个人防护设备。

P314: 如果你感到不适,请就医。

P308+P313: 如接触到或有疑虑:求医/就诊。

P405: 密闭存放

P501: 将内容物/容器送到批准的废物处理厂处理

质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
技术文档和文章
溶液计算器